+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Clinical Trials Sector Scorecard - Thematic Research - Product Thumbnail Image

Clinical Trials Sector Scorecard - Thematic Research

  • Report
  • October 2021
  • 24 Pages
  • Global
From
Malignant Pleural Effusion - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Malignant Pleural Effusion - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 128 Pages
  • Global
From
Stroke - Pipeline Review, H2 2020 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 773 Pages
  • Global
From
Europe Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Europe Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 98 Pages
  • Europe
From
LAMEA Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

LAMEA Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 99 Pages
  • Africa, Middle East
From
Asia Pacific Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Asia Pacific Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 99 Pages
  • Asia Pacific
From
North America Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

North America Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 86 Pages
  • North America
From
PharmSource - Bio/Pharma CapEx Trends - 2019 Edition - Product Thumbnail Image

PharmSource - Bio/Pharma CapEx Trends - 2019 Edition

  • Report
  • December 2019
  • 32 Pages
  • Global
From
Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition - Product Thumbnail Image

Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition

  • Report
  • June 2021
  • 55 Pages
  • Global
From
Secondary Progressive Multiple Sclerosis Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Secondary Progressive Multiple Sclerosis Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2022
  • 102 Pages
  • Global
From
Impact of Inflation on the Healthcare Sector by Physicians Perspective, Patient Treatment, Regional Analysis, Drug Prices and Treatment Costs - Thematic Intelligence - Product Thumbnail Image

Impact of Inflation on the Healthcare Sector by Physicians Perspective, Patient Treatment, Regional Analysis, Drug Prices and Treatment Costs - Thematic Intelligence

  • Report
  • June 2023
  • 81 Pages
  • Global
From
Spinocerebellar Ataxia (SCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Spinocerebellar Ataxia (SCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 91 Pages
  • Global
From
Rheumatoid Arthritis (RA) Therapy Area Report - Product Thumbnail Image

Rheumatoid Arthritis (RA) Therapy Area Report

  • Report
  • February 2022
  • 65 Pages
  • Global
Migraine - Pipeline Review, H2 2020 - Product Thumbnail Image

Migraine - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 342 Pages
  • Global
From
North America RNA Based Therapeutic Market By Type, By Application, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021-2027 - Product Thumbnail Image

North America RNA Based Therapeutic Market By Type, By Application, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021-2027

  • Report
  • January 2022
  • 75 Pages
  • North America
From
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts - Product Thumbnail Image

Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

  • Report
  • December 2018
  • 180 Pages
  • Global
From
Asia Pacific RNA Based Therapeutic Market By Type, By Application, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021-2027 - Product Thumbnail Image

Asia Pacific RNA Based Therapeutic Market By Type, By Application, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021-2027

  • Report
  • January 2022
  • 84 Pages
  • Asia Pacific
From
Europe RNA Based Therapeutic Market By Type, By Application, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021-2027 - Product Thumbnail Image

Europe RNA Based Therapeutic Market By Type, By Application, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021-2027

  • Report
  • January 2022
  • 83 Pages
  • Europe
From
LAMEA RNA Based Therapeutic Market By Type, By Application, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021-2027 - Product Thumbnail Image

LAMEA RNA Based Therapeutic Market By Type, By Application, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021-2027

  • Report
  • January 2022
  • 84 Pages
  • Middle East, Africa
From
Bone Marrow Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bone Marrow Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 555 Pages
  • Global
From
Loading Indicator